CAMBRIDGE, U.K. & SAN JOSE, Calif.—A strategic collaboration between Abcam plc and Molecular Devices LLC is underway as the companies pursue the development of a collection of fast, reproducible screening tools for researchers. Abcam and Molecular Devices will combine their proprietary technologies to develop high-sensitivity fluorescent ELISA kits with Abcam noting in a press release that “the new CatchPoint SimpleStep ELISA kits combine the simplicity and speed of Abcam’s SimpleStep ELISA protocol, with its assay time of 90 minutes or less, with Molecular Devices’ fluorescent CatchPoint technology to facilitate enhanced protein detection for researchers seeking a fast, reproducible, high-sensitivity solution that has been validated on the leading fluorometric instruments.” These kits will be available for research use only, and can be accessed at http://www.abcam.com/kits/catchpoint-simplestep-elisa-kits.